ANI Pharmaceuticals Stock (NASDAQ:ANIP)
Previous Close
$78.53
52W Range
$62.61 - $99.50
50D Avg
$81.06
200D Avg
$81.50
Market Cap
$1.77B
Avg Vol (3M)
$340.30K
Beta
0.43
Div Yield
-
ANIP Company Profile
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANIP Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Total Sales of Generics and Other | $399.41M | $320.03M | - |
| Sales of rare disease pharmaceutical products | $422.65M | $229.60M | $112.12M |
| Sales of Established Brands | $61.31M | $64.74M | - |
| Unapproved Products | - | $22.40M | - |
| Sales of established brand pharmaceutical products | - | - | $105.25M |
| Sales of generic pharmaceutical products | - | - | $269.45M |
Fiscal year ends in Dec 25 | Currency in USD